PMID- 24578521 OWN - NLM STAT- MEDLINE DCOM- 20140909 LR - 20151119 IS - 1538-6724 (Electronic) IS - 0031-9023 (Linking) VI - 94 IP - 7 DP - 2014 Jul TI - Muscle atrophy, voluntary activation disturbances, and low serum concentrations of IGF-1 and IGFBP-3 are associated with weakness in people with chronic stroke. PG - 957-67 LID - 10.2522/ptj.20130322 [doi] AB - BACKGROUND: The muscle weakness that is exhibited poststroke is due to a multifactorial etiology involving the central nervous system and skeletal muscle changes. Insulinlike growth factor 1 (IGF-1) and IGF binding protein 3 (IGFBP-3) have been described as biomarkers of neuromuscular performance in many conditions. However, no information about these biomarkers is available for people with chronic hemiparesis. OBJECTIVE: The purpose of this study was to investigate possible factors involved in muscle weakness, such as IGF-1 and IGFBP-3 serum concentrations, muscle volume, and neuromuscular performance of the knee flexors and extensors, in people with chronic hemiparesis poststroke. DESIGN: This was a cross-sectional study. METHODS: A cross-sectional study was performed on 14 individuals poststroke who were paired with healthy controls. Mobility, function, balance, and quality of life were recorded as outcome measures. Knee flexor and extensor muscle volumes and neuromuscular performance were measured using nuclear magnetic resonance imaging, dynamometry, and electromyography. The serum concentrations of IGF-1 and IGFBP-3 were quantified by enzyme-linked immunosorbent assay (ELISA). RESULTS: The hemiparetic group had low serum concentrations of IGF-1 (25%) and IGFBP-3 (40%); reduced muscle volume in the vastus medialis (32%), vastus intermedius (29%), biceps femoris (16%), and semitendinosus and semimembranosus (12%) muscles; reduced peak torque, power, and work of the knee flexors and extensors; and altered agonist and antagonist muscle activation compared with controls. CONCLUSIONS: Low serum concentrations of IGF-1 and IGFBP-3, deficits in neuromuscular performance, selective muscle atrophy, and decreased agonist muscle activation were found in the group with chronic hemiparesis poststroke. Both hemorrhagic and ischemic stroke were considered, and the data reflect a chronic poststroke population with good function. CI - (c) 2014 American Physical Therapy Association. FAU - Silva-Couto, Marcela de Abreu AU - Silva-Couto Mde A AD - M.A. Silva-Couto, MS, Department of Physical Therapy, Federal University of Sao Carlos, Rodovia Washington Luis, Km 235, Monjolinho, Sao Carlos, Sao Paulo, Brazil 13565-905. marcela.deabreu@yahoo.com.br russo@ufscar.br thiagoluizrusso@gmail.com. FAU - Prado-Medeiros, Christiane Lanatovitz AU - Prado-Medeiros CL AD - C.L. Prado-Medeiros, PhD, Department of Physical Therapy, Federal University of Sao Carlos. FAU - Oliveira, Ana Beatriz AU - Oliveira AB AD - A.B. Oliveira, PhD, Department of Physical Therapy, Federal University of Sao Carlos. FAU - Alcantara, Carolina Carmona AU - Alcantara CC AD - C.C. Alcantara, MS, Department of Physical Therapy, Federal University of Sao Carlos. FAU - Guimaraes, Araci Teixeira AU - Guimaraes AT AD - A.T. Guimaraes, Department of Physical Therapy, Federal University of Sao Carlos. FAU - Salvini, Tania de Fatima AU - Salvini Tde F AD - T.F. Salvini, PhD, Department of Physical Therapy, Federal University of Sao Carlos. FAU - Mattioli, Rosana AU - Mattioli R AD - R. Mattioli, PhD, Department of Physical Therapy, Federal University of Sao Carlos. FAU - de Russo, Thiago Luiz AU - de Russo TL AD - T.L. Russo, PhD, Laboratorio de Pesquisa em Fisioterapia Neurologica (LaFiN) and Department of Physical Therapy, Federal University of Sao Paulo, Rodovia Washington Luis, Km 235, Monjolinho, Sao Carlos, Sao Paulo, Brazil 13565-905. marcela.deabreu@yahoo.com.br russo@ufscar.br thiagoluizrusso@gmail.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140227 PL - United States TA - Phys Ther JT - Physical therapy JID - 0022623 RN - 0 (Biomarkers) RN - 0 (Insulin-Like Growth Factor Binding Protein 3) RN - 67763-96-6 (Insulin-Like Growth Factor I) SB - IM MH - Aged MH - Biomarkers/blood MH - Case-Control Studies MH - Cross-Sectional Studies MH - Electromyography MH - Female MH - Humans MH - Insulin-Like Growth Factor Binding Protein 3/*blood MH - Insulin-Like Growth Factor I/*metabolism MH - Knee/physiopathology MH - Magnetic Resonance Imaging MH - Male MH - Middle Aged MH - Muscle Strength/physiology MH - Muscle Strength Dynamometer MH - Muscular Atrophy/*blood/etiology/physiopathology MH - Paresis/*blood/complications/physiopathology MH - Postural Balance MH - Quadriceps Muscle/pathology/*physiopathology MH - Quality of Life MH - Stroke/blood/complications/*physiopathology MH - Torque MH - Walking EDAT- 2014/03/01 06:00 MHDA- 2014/09/10 06:00 CRDT- 2014/03/01 06:00 PHST- 2014/03/01 06:00 [entrez] PHST- 2014/03/01 06:00 [pubmed] PHST- 2014/09/10 06:00 [medline] AID - ptj.20130322 [pii] AID - 10.2522/ptj.20130322 [doi] PST - ppublish SO - Phys Ther. 2014 Jul;94(7):957-67. doi: 10.2522/ptj.20130322. Epub 2014 Feb 27.